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Skin cancer, previously known to be a common disease in Western countries, is
becoming more common in Asian countries. Skin cancer differs from other carcinomas
in that it is visible to our eyes. Although skin biopsy is essential for the diagnosis of
skin cancer, decisions regarding whether or not to conduct a biopsy are made by an
experienced dermatologist. From this perspective, it is easy to obtain and store photos
using a smartphone, and artificial intelligence technologies developed to analyze these
photos can represent a useful tool to complement the dermatologist’s knowledge. In
addition, the universal use of dermoscopy, which allows for non-invasive inspection of the
upper dermal level of skin lesions with a usual 10-fold magnification, adds to the image
storage and analysis techniques, foreshadowing breakthroughs in skin cancer diagnosis.
Current problems include the inaccuracy of the available technology and resulting legal
liabilities. This paper presents a comprehensive review of the clinical applications of
artificial intelligence and a discussion on how it can be implemented in the field of
cutaneous oncology.
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INTRODUCTION
The increasing incidence of skin cancer is a global trend. Skin cancer, which was previously
known to be a common disease in Western countries, is occurring more frequently in South
Korea. According to the Korean Statistical Information Service1, the number of patients with non-
melanoma skin cancer in 2015 was 4,804 (9.4 people per 100,000), an increase over the 1,960 in
2005 and 3,270 in 2010. The increase in incidence rate is thought to be due to the aging population,
the increased popularity of outdoor activities, increased ultraviolet exposure, improved access to
medical services, and increased awareness of skin cancer among patients (1).
Skin biopsy and histopathologic evaluation are essential in confirming skin cancer. However,
it is impossible to confirm all pigmented lesions by biopsy due to pain and scar development.
Therefore, it is first necessary to establish whether or not a biopsy is required through a visual
inspection performed by an experienced dermatologist. Furthermore, dermatologist needs a device
that can detect changes over time in skin lesions and record the lesions in detail so that wrong-site
surgery does not occur (2, 3).
With the development of imaging technologies, methods and devices for recording and
analyzing what doctors see have progressed rapidly. Universally, dermoscopic imaging irradiates
light onto the upper dermal layer, to observe and record more detailed pigment changes. In recent
years, development of high-resolution non-invasive diagnostic devices (e.g., confocal microscopy,
multiphoton microscopy, etc.) that can detect cellular levels of the skin lesions without biopsy has
also been enriched (4–6). In addition, diagnoses of such skin images using artificial intelligence
1http://kosis.kr/statHtml/statHtml.do?orgId=117&tblId=DT_117N_A00025&conn_path=I2
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FIGURE 1 | Relationship between artificial intelligence, machine learning, and deep learning.
(AI) have been shown to outperform the average diagnosis
performances of doctors. These developments are expected to
have a significant impact on the diagnosis of skin cancer,
the accurate recording of changes in suspicious lesions, and
the effectiveness of follow-up skin cancer surgery. For user
convenience, applications suitable for general smartphones have
become available; however, these are not sufficiently supported by
scientific evidence.
In this review, we introduce the basic concepts and clinical
applications of AI via a literature review and discuss how these
can be implemented in the field of dermatological oncology.
BASIC CONCEPTS OF ARTIFICIAL
INTELLIGENCE
AI is a field of computer science that solves problems by
imitating human intelligence, these problems typically require
the recognition of patterns in various data. Conventional
machine learning refers to machine learning methods that
do not involve deep learning; these methods extract features
such as those relating to colors, textures, and edges. In
conventional machine learning, precise engineering knowledge
Abbreviations: ACC, accuracy; AI, artificial intelligence; ALM, acral lentiginous
melanoma; AUC, area under the curve; BCC, basal cell carcinoma; BN, benign
nevus; BoF, bag of features; CLAHE, contrast-limited adaptive histogram
equalization; CNN, convolutional neural network; DCNN, deep convolution
neural network; DI, dice score; DLNN, deep learning-based neural network;
FFOCT, full-field optical coherence tomography; GAC, geodesic active contour;
GLCM, gray-level co-occurrence matrix; ICA, independent component
analysis; ILSVRC, ImageNet large-scale visual recognition challenge; ISBI,
International Symposium on Biomedical Imaging; ISIC, International Skin
Imaging Collaboration; JA, Jaccard index; KNN, k-nearest neighbor; LFN,
lesion feature network; LICU, lesion index calculation unit; LIN, lesion indexing
network; MLP, multi-layer perceptron; MM, malignant melanoma; NPV, negative
predictive values; OCT, optical coherence tomography; PCA, principal component
analysis; PPV, positive predictive values; PS-OCT, polarization-sensitive optical
coherence tomography; RF, random forest; SCC, squamous cell carcinoma; SGNN,
self-generating neural network; SK, seborrheic keratosis; Sen, sensitivity; Spe,
specificity; SVM, support vector machine.
and extensive experience are required to design feature extractors
capable of extracting suitable features. Using these features,
conventional machine learning can derive various results and
identify correlations.
Deep learning uses deep neural networks to learn features,
which are obtained by designing simple but non-linear modules
for each layer. Using deep neural networks, very complex
functions can be learned. For example, in the field of computer
vision, a deep neural network’s first layer typically learns the
presence of edges at particular orientations and locations within
the image. Larger combinations of such edges are identified in
the next layer. As the layers become deeper, they learn larger and
more specific features (7).
Figure 1 shows the relationship between AI, machine
learning, and deep learning. Deep learning falls within the
category of machine learning, which falls within the category
of AI. In this figure, the examples for conventional machine
learning and deep learning are classifications of acral lentiginous
melanoma (ALM) and benign nevus (BN) in dermoscopy images.
Conventional machine learning extracts specific features from
dermoscopy images; for example, the gray-level co-occurrence
matrix (GLCM) is used to extract texture features (8). The
conventional machine learning method then trains classifiers,
using the extracted features to classify ALM and BN. However,
deep learning methods learn by extracting various features
through deep neural networks. The main difference between
conventional machine learning and deep learning is that deep
learning extracts various features per layer, without human
intervention (9).
We divided the cutaneous oncology publications into those
evaluating malignant skin cancers and non-melanoma skin
cancers. In addition, each publication was divided into machine
learning (excluding deep learning), deep learning, and hybrid
methods (a combination of machine learning and deep learning)
(Figure 2).
In terms of machine learning methods, most publications
use a feature extractor to extract a feature from an image,
they then train the classifier model using these features
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(e.g., malignant melanoma (MM) vs. BN). Recently, deep
convolution neural network (DCNN) have been implemented in
many medical-imaging studies (10–12). DCNN use convolution
operations to compensate for the problems that arise through
neglecting the correlations and pixel localities of multi-layer
perceptron (MLP). Thus, deep learning can be used to train a
robust classifier model with a variety of data. Figure 3 shows
an example of a DCNN for classifying ALMs and BNs in
dermoscopic images. The DCNN feature extractor repeatedly
applies convolution and max-pooling (to obtain the largest
activation for each region) operations to the layer input. This
process generates a feature map. The feature map is inputted
to a classifier via global average pooling for each channel.
The classifier finally determines probabilities for ALM and
BN. The result is then compared with the actual label, and
the parameters are updated via backpropagation. However,
DCNN operations require highly powerful graphics processing
units to manage the complex computations and large datasets
involved. Although DCNN learning capacities can be limited
FIGURE 2 | Number of publications employing artificial intelligence in
cutaneous oncology.
by insufficient medical-image data, it is possible to fine-tune
state-of-art deep learning models that show high performance
in ImageNet large-scale visual recognition challenge (ILSVRC),
making them suitable for medical purposes (13). In the hybrid
method, an ensemble classifier is designed by combining a
conventional machine learning method and a deep learning
method. For example, after extracting the features of an image
using a conventional machine learning method, these extracted
features are used as inputs for a DCNN. Another example is that
of training a support vector machine (SVM) using a feature map
obtained through a DCNN (14). One publication showed that
hybrid models outperform both deep learning and conventional
machine learning models (15), another publication highlighted
the limitations of deep learning and stated a need for hybrid
models to overcome these limitations (16). Thus, these two
methods can be used effectively to create more accurate models.
Every year, the number of articles describing AI
implementations in the field of cutaneous oncology increases. By
observing the trends of the discipline, it can be seen that studies
using conventional machine learning have been decreasing
in popularity since 2015 (five publications in 2015, three
publications from 2016 to 2017, and one publication after
2018); however, the number of studies conducted using deep
learning methods has increased significantly since 2015 (zero
publications in 2015, seven publications from 2016 to 2017, and
nine publications after 2018). These tendencies are a result of
the increasing availability of big data and powerful GPUs. Since
2015, state-of-art deep learning models such as ResNet have also
been studied [ResNet competed for the first time in the 2015
ILSVRC (17); it surpassed the human error rate of 5%, achieving
an error rate of 3.6%].
APPLICATION OF ARTIFICIAL
INTELLIGENCE IN THE DIAGNOSIS OF
MALIGNANT SKIN CANCERS
Melanoma
A total of 18 publications were identified, six of these described
the use of conventional machine learning, nine publications
FIGURE 3 | Example of DCNN for classifying ALM and BN in dermoscopic images. In the feature extractor, each layer performs a convolution operation on the input
data and then performs a max-pooling operation, thereby reducing the image size and increasing the number of channels. The feature extractor generates a feature
map by repeating this process for each layer. After the global average pooling operation, the feature map is used as the input of the classifier layer (fully-connected
layer). Finally, the output of the fully-connected layer appears as a probability of ALM or BN.
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showed the use of deep learning, and two publications presented
the use of hybrid models. Among the total 18 publications, 14
used dermoscopic images as the dataset, and the remainder used
unspecified or clinical images; nine used more than 500 datasets,
and the remainder used <500 datasets. Moreover, in five of the
publications, other skin lesion data such as seborrheic keratosis
(SK) and basal cell carcinoma (BCC) were used alongside
malignant melanomas and nevus. Seven publications presented
the area under the curve (AUC) as a performance indicator of the
model and the remainder presented accuracy (Acc), sensitivity
(Sen), and specificity (Spe) (Tables 1–3).
Deep Learning
Among the deep learning algorithms discussed in the literature,
five were fine-tuned using pre-trained models. The remainder
were fully trained with new models. In four publications,
preprocessing was performed prior to model training. In
addition, two publications performed lesion segmentation and
classification or segmentation of dermoscopic features. To
measure the model performance, one publication (Tschandl,
Kittler et al.) compared the results of final-year medical students
with those of the model; two publications (Yang et al. and
Lee et al.) used the results of dermatological experts as the
comparison. From these, Lee et al. showed that experienced
dermatologists and inexperienced dermatologists improved their
decision making with the help of deep learning models.
One publication (Premaladha and Ravichandran) compared
the conventional machine learning method ’Hybrid Adaboost-
SVM’ and a deep learning-based neural network on the same
dataset; they showed that the deep learning-based neural network
delivered superior performance. Moreover, one publication (Cui
et al.) demonstrated that when more data was used, the
results of deep learning outperformed conventional machine
learning methods.
Conventional Machine Learning
From the conventional machine learning publications, four of
the five publications performed feature extraction and then
created a classifier. Two of these publications used SVM for
the classifier, one used multivariable linear regression, and one
used a layered model. In three publications, artifact removal or
lesion segmentation were performed prior to feature extraction.
On the other hand, one publication (Marchetti, Codella et al.)
presented a new model using a fusion method, developed by 25
teams participating in International Symposium on Biomedical
Imaging (ISBI) 2016.
Hybrid (Deep Learning + Machine Learning)
In the publications using hybridmethods, one publication (Jafari,
Nasr-Esfahani et al.) preprocessed the input images, extracted
the patches, and performed segmentation using a convolutional
neural network (CNN). In one publication (Xie, Fan et al.),
segmentation was performed after preprocessing, using a neural
network called self-generating neural network (SGNN); they then
presented an ensemble network by designing a feature extractor
and classifier. Furthermore, in one publication (Sabbaghi et al.),
a deep auto-encoder combined with bag of features (BoF)
outperformed themodel using a BoF or deep auto-encoder alone.
Non-melanoma Skin Cancer: BCC,
Squamous Cell Carcinoma (SCC)
We identified seven deep learning publications, three machine
learning publications and three hybrid publications on non-
melanoma skin cancer. Several publications discussed MM;
however, all of them discussed BCC and three publications
discussed SCC, thus we classified the publications into these
categories. The results are organized in Tables 4–6.
The results of all publications were presented using an
accuracy indicator, and some of these publications using a variety
of indicators, such as specificity, sensitivity, precision, and F1
score. The datasets used in each publication were different,
making it impossible to compare them directly.
Deep Learning
Rezvantalab et al. compared the abilities of deep learning
against the performances of highly trained dermatologists. This
publication presented outcomes from various deep learning
models. In the BCC classification, the highest AUC of the
publication was reported as 99.3%, using DenseNet 201. When
compared against dermatologists (AUC 88.82%), the results of
deep learning were found superior.
Five publications used datasets of dermoscopic images. One
used full-field optical coherence tomography (FFOCT) images,
and Jordan Yap et al. used different forms of data including
metadata, macroscopic images, and dermoscopic images. Next,
they trained a deep learning model using fusion techniques, in
which image feature vectors were concatenated with themetadata
feature vectors. Two publications by Zhang et al. written in
2017 and 2018, showed interesting results; the 2018 publication
improved the previous year’s algorithm for utilizing medical
information. Their results showed an average improvement of
0.7% over those of the previous year.
Conventional Machine Learning
We identified four publications that used only machine learning
techniques. Three publications used dermoscopic images and one
used polarization-sensitive optical coherence tomography (PS-
OCT) images. Each author used different methods and features.
Marvdashti et al. performed feature extraction and
classification using multiple machine learning methods [SVM,
k-nearest neighbor (KNN)]. Kharazmi et al. segmented vascular
structures using independent component analysis (ICA) and
k-means clustering, then classified them using a random forest
classifier. Kefel et al. introduced automatically generated borders
using geodesic active contour (GAC) and Otsu’s threshold for
the detection of pink blush features, known as a common feature
of BCCs. Subsequently, they classified using logistic regression,
based on features such as smoothness and brightness.
Hybrid (Deep Learning + Machine Learning)
Three publications implementing hybrids were identified. Each
publication used a different dataset. One publication used
optical coherence tomography (OCT) images and another used
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TABLE 1 | Melanoma skin cancer publications using deep learning method.
Publication End-point Results Method Dataset
Li et al. (18) – Lesion segmentation (task1)
– Lesion dermoscopic feature
extraction (task2)
– Lesion classification (task3)
Task 1: JA : 0.710 (LIN)
Task 2 :AUC : 0.848 (LFN)
Task 3 :AUC : 0.912 (LIN with
LICU)
– Task 1 and Task 3
Preprocessing:
Center crop + Resize(320*320)
Data augmentation
Task 1 used LIN








ISIC 2017 dataset (n = 2000)
The dataset contains melanoma,
SK and nevus
Pour et al. (19) – Lesion segmentation

















– Lesion segmentation : Deeper model
with 16 conv. layers, augmentation
by flipping and cropping (7200
training images)
– Lesion dermoscopic feature
segmentation:
Similar convolutional layers initialized
with a pre-trained model from lesion
segmentation phase. This
architecture is followed by two parts,
each contains two convolutional
layers and four deconvolutional layers
to predict masks for both streak and
globule features.
ISBI 2016 challenge dataset
The dataset contains a
representative mix of images of
both MM and BN
– Lesion segmentation:
Train_Images (n = 900)
Test_Images (n = 379)
– Lesion dermoscopic feature
segmentation:
Train_Images (n = 807)
Test_Images (n = 335)














Data augmentation : 12 patches
cropping, rotation, and flipping
CNN: 5-layer convolution network +
FC
– Testing
Cropping 12 patches per test image
and when one or more images were
predicted as containing melanoma,
the corresponding test image was
interpreted as containing melanoma
Dermoscopic images
ALM (n = 350) and BN (n =
374)
– Group A










Pre-processing : Removal of noise and
illumination artifacts
CNN: 2-layer convolution network (20
feature maps and 50 feature maps) +
FC
Clinical images






Classification (MM and BN)




Pre-processing : CLAHE and median
filter
Segmentation : Normalized Otsu’s
segmentation (NOS)
Classifier : Compared DLNN and hybrid








– ISBI 2017 challenge dataset
AUC : 0.958
– ISBI 2016 challenge dataset
AUC : 0.874
Pre-processing : luminance and color
balance of input images are normalized
exploiting color constancy
CNN :
Fine-tuned 50-layer ResNet MM
classifier and SK classifier
Ensemble classifier made by merging
two classifiers
ISBI 2017 challenge dataset
Train_Images : provided data
(374MM, 254 SK, 1372 nevi) +
external data (409MM, 66 SK, 969
nevi)
Test_Images (n = 150)
(Continued)
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TABLE 1 | Continued
Publication End-point Results Method Dataset
Tschandl et al. (24) Classification (melanoma, BCC,
dermatofibroma, melanocytic naevi,










All images from the students’ training
session were also used to retrain the
last layer of the “GoogLeNet Inception
v3” neural network, without any kind of
test-set augmentation (4,000 epochs,
learning rate 0.001, batch size 50).
Dermoscopic images (n = 348)
Train_Images (n = 298):
melanoma (n = 62), BCC (n = 40),
dermatofibroma (n = 7),
melanocytic naevi (n = 129), SK (n
= 38), and vascular lesion (n = 22)
Test_Images (30%):
melanoma (n = 10), BCC (n = 10),
dermatofibroma (n = 2),
melanocytic naevi (n = 14), SK (n =
9) and vascular lesion (n = 5)
Esteva et al. (25) Classification (757 diseases) – 3-way classification
Dermatologist 1 Acc: 65.6%
Dermatologist 2 Acc: 66.0%
CNN Acc: 69.4 ± 0.8%
CNN – partitioning algorithm
Acc: 72.1 ± 0.9%
– 9-way classification
Dermatologist 1 Acc: 53.3%
Dermatologist 2 Acc: 55.0%
CNN Acc: 48.9 ± 1.9%
CNN – partitioning algorithm
Acc: 55.4 ± 1.7%
– Training Using Google Inception v3
CNN architecture pretrained on the
ImageNet dataset (1.28 million
images of over 1,000 generic object
classes) and fine-tuned on their own
dataset of 129,450 skin lesions
comprising 2,032 different diseases.
The 757 training classes were
defined using a novel taxonomy of
skin diseases and a partitioning
algorithm that maps diseases into
training classes.
– Testing Author developed an
algorithm to partition diseases into
fine-grained training classes (for
example, amelanotic melanoma and
acral lentiginous melanoma). During
inference, the CNN outputs a
probability distribution over these fine
classes. To recover the probabilities
for coarser-level classes of interest
(for example, melanoma) they
summed the probabilities of
their descendants
Dermoscopic and conventional
images (n = 129,450)
Train_Images (n = 127,463)
Test_Images (n = 1,942)













Made an ensemble model [merging
Model 2 (intermediate tumor in BN set)
and Model 3 (intermediate tumor in
ALM set)]
Dermoscopy images
ALM (n = 500), BN (n = 500) and
intermediate tumor (n = 72)
Train_Images (n = 872):
ALM (n = 400), BN (n = 400) and
intermediate tumor (n = 72)
Test_Images (n = 200):
ALM (n = 100), BN (n = 100)
Cui et al. (27) Classification (melanoma and
non-melanoma)
– CNN





Fine-tuned CNNs (AlexNet, VGG16,
VGG19, Inception V3) and compared
CNNs (best model was Inception V3)
Dermoscopy images
deep learning dataset (n = 2,200):
melanoma (n = 564) and
non-melanoma (n = 1,636)
dermoscopic images. Unusually, the third publication used data
downloaded from the Internet, not directly taken.
Annan Li et al. used deep learning for feature extraction,
then classified images using the principal component analysis
(PCA) and SVM machine learning techniques. They compared
deep learning models and assessed the differences in dimensions
of the PCA features. Sarkar et al. applied Gaussian blurring
to denoise the images and then used the contrast-limited
adaptive histogram equalization (CLAHE) algorithm to enhance
them. Unlike previous publications, deep learning was used
for classification.
IMPLEMENTATION IN SMARTPHONES
With the spread of smartphones, the mobile application market
has expanded rapidly. Applications can be used in various
fields, particularly in the field of dermatology through the
use of smartphone cameras. In particular, due to the ubiquity
of smartphones, easily accessible mobile apps can make it
more efficient to detect and monitor skin cancers during
the early stages of development. In addition, with the recent
development of smartphone processors and cameras, machine
learning techniques can be applied, and skin cancer diagnoses
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TABLE 2 | Melanoma skin cancer publications using conventional machine learning method.
Publication End-point Results Method Dataset
Sabouri et al. (28) Classification (MM and BN) Sen: 89.28%
Spe: 100%
(best model: cascade classifier)
Pre-processing:





Color features: RGB and HSV
Texture features: using GLCM
Classifier: compared many models
(KNN, MLP, Naïve Bayes, RF, SVM).
Best model was cascade SVM
Classifier (SVM #1 using normalized
HSV, SVM #2 using a combination of
color and texture features)
Unspecified images
Train_Images (n = 370):
MM (n = 175) and BN (n = 195)
Test_Images (n = 42):
MM (n = 16) and BN (n = 26)
Kaur et al. (29) Pink lesion classification within MM
or BN
AUC: 0.879 (all features) Relative color thresholds




Blob features (5 per shade)
Color features for each pink shade over
entire lesion (15 per shade)
Texture features derived from lesion
histogram (24 per shade)
Location features (6 per shade)
Classifier : multivariate analysis using
linear regression was performed using
the Proc Logistic function in SAS
Dermoscopic images.
Train_Images (n = 60):
Only MM containing visible pink
areas within the lesion
Test_Images (n = 132):
MM (n = 54), benign dysplastic,
and congenital nevi (n = 78)
Shimizu et al. (30) 4-class classification (melanoma,




(AUC denotes the area of the
receiver-operating characteristic
(ROC) curve between %M and
min (%N, %B, %S).)
Border detection : The core of the
algorithm was color thresholding,
removal of artifacts such as microscope
border and hair, and inclusion of bright
area seen specifically in NoMSLs (BCC
and SK)
Feature extraction:
Color-related Features : calculating ten
statistics for the intensity of six color
channels (RGB, HSV)
Subregion-related features : describing
geometrical distribution of the color.
Texture-related features : by adopting
GLCM




Test_Images (n = 964):
melanoma (n = 105), nevi (n = 692),
and SK (n = 98), BCC (n = 69)
Abedini et al. (31) Classification (MM and BN) Acc: 0.90
(accuracy continues to improve
with some fluctuation before
converging at approximately
90% after 150 responses.)
One feature of the system enables the
domain expert to improve previously
built models.
Classifier with a stochastic gradient
descent SVM and a feedback
mechanism.
Eventually, as more feedback is
provided (more training examples), the
SVM accuracy improves.
Dermoscopic images
Train_Image (n = 100)
Test_Image (n = 5):
melanoma (n = 3) and normal skin
(n = 2)
Marchetti et al. (32) Classification (MM and BN)









Compared five methods of fusing all
automated predictions from the 25
participating teams in the ISBI
challenge into a single prediction (three
machine learning methods and two
non-learned approaches)
ISBI 2016 challenge dataset
The dataset contains a
representative mix of images of both
MM (n = 248) and BN (n = 1,031)
Train_Images (n = 900)
Test_Images (n = 379)
Reader study images (n = 100):
MM (n = 50) and BN (n = 50)
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TABLE 3 | Melanoma skin cancer publications using hybrid method.
Publication End-point Results Method Dataset









Normal skin patch selection






Global and local patch definition
CNN: local texture analysis + general
structure analysis
Post-processing : selecting largest
connected component, dilation and
hole filling
Clinical images (n = 126)
MM (n = 66) and non-MN (n = 60)
Train_Images (75%)
Test_Images (25%)
Xie et al. (34) Classification (melanoma and
nevus)












Region division on dermoscopy images




Classifier: meta-ensemble model of
multiple neural network ensembles
Ensemble 1: single-hidden-layer BP
nets with same structures
Ensemble 2: single-hidden-layer BP
nets and fuzzy nets
Ensemble 3: double-hidden-layer BP
nets with different structures
Dermoscopy images
– Xanthous race dataset (n = 240):
MM (n = 80) and BN (n = 160)
– Caucasian race dataset (n =




Classification (MM and BN) Sen: 95.5%
Spe: 94.9%
Acc: 95%
(Deep auto-encoder with BoF)
Each RGB dermoscopy image from a
training set is converted to BoF mode
Then, the generated BoF
(scale-invariant feature transform (SIFT)
+ color) are fed into the stack
auto-encoder for training
Dermoscopic images.
MM (n = 174) and BN (n = 640)
Train_Images (n = 570)
Test_Images (n = 244)
can be conducted through smartphones. Table 7 shows that a
lot of research and development on smartphone implementation
is carried out. AI technology relevant to skin cancer diagnosis
is anticipated to eventually be implemented in smartphones,
enabling the reduction of unnecessary hospital visits. Many types
of mobile health application are already available.
Types and Accuracies of Diagnostic
Applications Using a Smartphone
According to a recent review (53, 54), numerous applications
have already been released, seven of which use image analysis
algorithms. Four of the seven applications are not supported by
scientific evidence, and these four have been deleted from the app
store since the review was conducted; the other three apps are
still available. Table 7 provides a summary of the apps. SkinScan,
SkinVision, and SpotMole are currently available. SkinVision
uses machine learning algorithms and SkinScan and SpotMole
use the ABCDE rule (that is asymmetry, border irregularity,
color that is not uniform, diameter >6mm, and evolving size,
shape or color). Only one application employs amachine learning
technique. The sensitivity and specificity of these applications are
shown in the table.
Most diagnosis applications are not accurate (55).
Furthermore, only a few inform users using image analysis
and machine learning. Most apps are not supported by scientific
evidence and require further research.
Problems and Possible Solutions
Inaccuracies in medical applications can result in problems
of legal liability. In addition, the transmission of patient
information may correspond to telemedicine practices, for
which there are certain legal restrictions; these include
Frontiers in Medicine | www.frontiersin.org 8 July 2020 | Volume 7 | Article 318
Chu et al. Artificial Intelligence in Cutaneous Oncology
TABLE 4 | Non-melanoma skin cancer publications using deep learning method.
Publication End-point Results Method Dataset
Rezvantalab et al.
(36)
Compare ability of deep learning







93.20% (Inception ResNet v2)










n = 10,015 dermoscopic images.
Melanoma (1,113 samples)
Melanocytic nevi (6,705 samples)
BCC (514 samples)
Actinic keratosis and intraepithelial
carcinoma (327 samples)
Benign keratoses (1,099 samples)
Dermatofibroma (115 samples)
Vascular lesions (142 samples)
n_train = 70%
n_val, n_test = 15%
Zhang et al. (37) Automatically classify dermoscopic






Pre-trained on over 1.28 million images
and adjusted the final layer to input own
datasets using transfer learning







132 (Nevus, SK, BCC, Psoriasis)
n_train = 80%
n_val, n_test = 10%
Vander Putten
et al. (38)
Demonstrate a sensitivity and
specificity that could make neural




AUC 0.92, Sen 0.98, Spe 0.95
98 layers
AUC 0.89, Sen 0.98, Spe 0.94
152 layers
AUC 0.93, Sen 0.97, Spe 0.96
1. Segmentation (deep residual
network)
2. Classification (very deep
residual network)
Two independent sources (BCC)
Dermoscopic images
1. “Skin Lesion Analysis
Toward Melanoma Detection”
competition released with ISBI
2016












– Fully connected layer
– Dropout layer
n = 40 FFOCT images
10 (BCC)
Zhang et al. (40) Machine learning algorithms need
to be combined with sufficient






Developed algorithm based on
pre-trained GoogLeNet Inception v3
In order to facilitate decision-making
and improve the accuracy algorithm,
this summarized
classification/diagnosis scenarios
based on domain expert knowledge
and semantically represented them in a
hierarchical structure







132 (Nevus, SK, BCC, Psoriasis)
n_train = 80%
n_val, n_test = 10%
Yap et al. (41) A method which combines multiple






Used pre-trained modified ResNet-50
architecture (to extract image features)
Using a late fusion technique
Image feature vectors were
concatenated together with the
metadata feature vectors and sent
through the embedding network




727 (All cutaneous melanomas




information protection regulations to prevent third parties
accessing data during the transmission process. Even if
the accuracy is improved, the advertisements embedded
in the application suggest that the technology could
be used for commercial advertisements; for example, to
attract patients.
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TABLE 5 | Non-melanoma skin cancer publications using conventional machine learning method.
Publication End-point Results Method Dataset
Marvdashti et al.
(42)
Fully automated procedure to





Extracting image features from the two
complementary image contrasts offered
by PS-OCT, intensity and phase
retardation (PR) using machine learning
Then, classify image features using SVM
with linear and Gaussian kernels, KNN,
and RF
n = 520 PS-OCT
260 (Healthy, 26 patients)
260 (BCC, 26 patients)
Kharazmi et al.
(43)
Detection and segmentation of
cutaneous vasculature from
dermoscopy images and extracted








Segment vascular structures by
decomposing the image using ICA,
k-means clustering
Then, a vessel mask is generated as a
result of global thresholding
Vascular features fed into an RF classifier
(decision tree)
n = 659 dermoscopy images
299 (BCC)
360 (Non-BCC)
Kefel et al. (44) Automatic method for detection of
pink blush
(common feature in BCC)






Border detection by GAC and modified
Otsu’s threshold
Classification:
logistic regression by Proc Logit of SAS
(smoothness, brightness)







To solve this problem, a supervisory institution in which
doctors participate is required, along with a connection
to remote medical care services. The United States has
been steadily attempting to promote telemedicine in its
early stages, to address the issue of access to healthcare.
Since the establishment of the American Telemedicine
Association (ATA)—a telemedicine research institute—in
1993, legislation, including the Federal Telemedicine Act,
has been established. It has been applied to more than 50
detailed medical subjects, including heart diseases, and has been
successfully implemented in rural areas, prisons, homes, and
schools (56).
To obtain good results, it is necessary to focus on
securing high-quality data, to form a consensus between
the patient and the doctor, and to actively participate
in development.
In summary, the evidence for the diagnostic accuracy
of smartphone applications is still lacking because few
mHealth apps offer services. In addition, because the rate
of service or algorithm change is faster than the peer-
review publishing process, it is difficult to compare different
apps accurately.
Risks of Smartphone Applications
Smartphone applications pose some risk to users, especially
if the algorithm returns negative results and delays the
detection and treatment of undiagnosed skin cancer. It is
very difficult to study false-negative rates because there is
no histological evidence. Users may not be able to assess all
skin lesions, especially if they are located in areas difficult to
reach or to see. Given the generally low specificity of current
applications, there would be a few false positives. This would put
unnecessary stress on the user and result in unnecessary visits
to the dermatologist. Furthermore, through limited trust and
awareness, the user may not follow the advice provided by the
smartphone application.
Chao et al. described the ethical and privacy issues of
smartphone applications (57). Whilst applications have the
potential to improve the provisions of medical services,
there are important ethical concerns regarding patient
confidentiality, informed consent, transparency in data
ownership, and protection of data privacy. Many apps
require users to agree to their data policies; however, the
methods in which patient data are externally mined, used,
and shared are often not transparent. Therefore, if a patient’s
data are stored on a cloud server or released to a third
party for data analysis, assessing liability in the event of a
breach of personal information is a challenge. In addition,
it is unclear how the responsibilities for medical malpractice
will be determined if the patient is injured as a result of
inaccurate information.
CONCLUSION
In this review, we analyzed a total of 35 publications. Studies
on skin lesions were divided into those assessing malignant
melanomas and non-melanoma skin cancers. In addition,
studies involving clinical data and OCT images were used
alongside those involving the dermoscopic images widely
used in dermatology. Because the considered datasets
differed between the publications, it was impossible to
determine how best to perform the analysis. However, as
seen in the publication by Cui et al. deep learning methods
obtain better results than conventional machine learning
methods if the dataset is large. Also, certain publications have
reported comparable or superior results to dermatologist. In


































TABLE 6 | Non-melanoma skin cancer publications using Hybrid method.
Publication End-point Results Method Dataset
Annan et al. (45) Propose BCC detection
method
Proposed method AUC (Best model : VGG-16)
ConvNet Ori Dimension of PCA feature
100 200 500 1,000
AlexNet 0.916 0.897 0.915 0.897 0.917
GoogLeNet 0.744 0.744 0.744 0.744 0.744
VGG-16 0.935 0.858 0.913 0.928 0.931
VGG-19 0.891 0.798 0.824 0.863 0.894
1. Graph based skin surface
segmentation
2. Surface flattening
3. Deep feature extraction (pre-trained
AlexNet, GoogLeNet,
VGG-16, VGG-19)
BCC classification (PCA, SVM)
n = 5,040 OCT images 1,875
(lesion or irregular structure)
Sarkar et al. (46) Novel state of the art deep















Denoising of images by Gaussian
blurring
Enhancement of images by CLAHE
algorithm and use parallel deep residual
network (RMSprop optimizer)
for classification
n = 700 dermoscopic images
300 (BCC positive)
100 (augmented set of SCC
positive)
300 (benign skin lesion)
n_train = 560
n_val = 140




Sen, % Spe, %
Actinic Keratoses 92.3 98.9 91.67
Basal cell carcinoma 91.8 97.7 86.73
Squamous cell carcinoma 95.1 96.9 94.17
Melanoma 94.2 97.83 90.74
Pre-trained AlexNet is used to extract
training features and the obtained
convolutional neural network features
are classified into four groups using
error-correcting output codes (ECOC),
SVM
n= 3,753 collected from the internet
Actinic Keratoses
– 712 (Train), 185 (Test)
BCC
– 728 (Train), 193 (Test)
SCC
– 777 (Train), 200 (Test)
Melanoma
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TABLE 7 | Smartphone applications.
Application name Algorithm Evidence Performance References
DermaCompare
(removed)
Machine learning Not found Not found [1]










MskinDoctor (removed) Grab cut algorithm
(segmentation), SVM
(classification)
Not found Not found [3]
MySkinMap (removed) Machine learning Not found Not found [4]
SkinScan Image processing technique,
ABCDE rule

























[1]AppAdvice. Derma Compare by Emerald Medical Applications. Available online at: https://appadvice.com/app/derma-compare/982517772.
[2]AppAdvice. Lubax - Skin Lesion ID Using Image Recognition by Lubax, Inc. Available online at: https://appadvice.com/app/lubax-skin-lesion-id-using-image-recognition/956423382.
[3]AppBrain. mSkin Doctor Mobile Application for Skin Cancer Detection by Aleem Technologies. Available online at: https://www.appbrain.com/app/mskin-doctor/com.maleemtaufiq.
mSkinDoctor.
[4]AppAdvice. MySkinMap by Xyrupt Technologies, LLC. Available online at: https://appadvice.com/app/myskinmap/1151655127.
[5]AppAdvice. SkinScan by TeleSkin ApS. Available online at: https://appadvice.com/app/skinscan/1025190936.
[6]SkinVision. Available online at: https://www.skinvision.com/.
[7]Google Play. SpotMole. Available online at: https://play.google.com/store/apps/details?id=com.spotmole&hl=nl.
particular, recent publications have reported that dermatologists
have improved diagnostic accuracy with the help of deep
learning (26, 58). Therefore, in the future, computer-aided
diagnostics in dermatology will show greater reliance on deep
learning methods.
For the convenience of users, the use of a smartphone is
necessary. However, an accuracy limitation occurs when applied
to smartphones. This problem is due to the limitations of
hardware, which used conventional machine learning techniques
such as SVM rather than deep learning. However, MobileNet has
recently made it possible to use deep learning methods in IoT
devices, including smartphones (59). This enables deep learning
to be applied to IoT devices for faster performances than large
networks, which will lead to more active research into skin lesion
detection using applications.
Application inaccuracies can lead to legal problems.
To solve this problem, doctors and patients must
participate together in the development stage, and an
institution for managing and supervising this process is
also required.
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